Literature DB >> 8587236

Interleukin-1-induced IL-8 and IL-6 gene expression and production in human mesangial cells is differentially regulated by cAMP.

R L Robson1, J Westwick, Z Brown.   

Abstract

We have previously proposed that activated mesangial cells (MC) have a direct role in the initiation and propagation of inflammatory events within the glomerulus via the generation of the mesangioproliferative cytokine IL-6 and the chemokines IL-8 and MCP-1. The objective of this study was to investigate the role of cAMP in the regulation of IL-6 and IL-8 gene expression and peptide production in IL-1 stimulated human MC. Agents known to elevate cAMP, including dibutyryl cAMP (db-cAMP), forskolin or isobutyl-methylxanthine (IBMX) were alone unable to induce IL-6 or IL-8 expression or production above media control levels, indicating activation of the cAMP pathway could not mimic IL-1 signaling events. In the presence of IL-1, all three agents produced a marked potentiation of IL-6 mRNA expression and dose-dependent increase in IL-6 peptide production (twofold), but had little or no effect on IL-8 mRNA expression or peptide generation. In marked contrast cholera toxin (CT) caused a dose-dependent potentiation of both IL-1-induced IL-6 (approximately fourfold) and IL-8 peptide (approximately twofold) generation. The control agent, the purified binding subunit of cholera toxin (CT-B) which is devoid of ADP-ribosylating activity also enhanced IL-6 and IL-8 (approximately twofold) peptide generation indicating cAMP-independent mechanisms may be involved in the CT up-regulation of these cytokines. Treatment of MC with the cycloxygenase inhibitor indomethacin resulted in partial inhibition (37%) of IL-6 production but had no effect on IL-8 generation. Thus our data show that cAMP can potentiate IL-1 induced IL-6 production, while having no effect on IL-8 induction, and PGE2 may operate via a positive feedback loop to up-regulate IL-1 induced IL-6. Taken together, our results demonstrate that cAMP differentially regulates IL-6 and IL-8 production in IL-1-stimulated human MC.

Entities:  

Mesh:

Substances:

Year:  1995        PMID: 8587236     DOI: 10.1038/ki.1995.475

Source DB:  PubMed          Journal:  Kidney Int        ISSN: 0085-2538            Impact factor:   10.612


  6 in total

Review 1.  Chemokines: understanding their role in T-lymphocyte biology.

Authors:  S G Ward; J Westwick
Journal:  Biochem J       Date:  1998-08-01       Impact factor: 3.857

Review 2.  Molecular mechanisms of actions of interleukin-6 on the brain, with special reference to serotonin and the hypothalamo-pituitary-adrenocortical axis.

Authors:  N Barkhudaryan; A J Dunn
Journal:  Neurochem Res       Date:  1999-09       Impact factor: 3.996

3.  Survival of trauma-injured neurons in rat brain by treatment with proline-rich peptide (PRP-1): an immunohistochemical study.

Authors:  Silva S Abrahamyan; John S Sarkissian; Irina B Meliksetyan; Armen A Galoyan
Journal:  Neurochem Res       Date:  2004-04       Impact factor: 3.996

Review 4.  IL-20 in Acute Kidney Injury: Role in Pathogenesis and Potential as a Therapeutic Target.

Authors:  Tian-Yu Lin; Yu-Hsiang Hsu
Journal:  Int J Mol Sci       Date:  2020-02-03       Impact factor: 5.923

5.  DPIE [2-(1,2-diphenyl-1H-indol-3-yl)ethanamine] Augments Pro-Inflammatory Cytokine Production in IL-1β-Stimulated Primary Human Oral Cells.

Authors:  Sun-Hee Ahn; Jin-Kyung Lee; Nam Doo Kim; Seok-Ho Kim; Sunwoo Lee; Seunggon Jung; Kee-Oh Chay; Tae-Hoon Lee
Journal:  Int J Mol Sci       Date:  2018-06-22       Impact factor: 5.923

6.  Anticancer and Immunomodulatory Activities of a Novel Water-Soluble Derivative of Ellipticine.

Authors:  Regiane Costa de Oliveira; Gemilson Soares Pontes; Aleksandr Kostyuk; Gabriel B Coutinho Camargo; Anamika Dhyani; Tetiana Shvydenko; Kostiantyn Shvydenko; Andriy Grafov
Journal:  Molecules       Date:  2020-05-01       Impact factor: 4.411

  6 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.